|
Evaluation of Patients with Heart Disease Not Eligible for Research Protocols Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Evaluation of Patients with Heart Disease Not Eligible for Research Protocols conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation of Patients with Heart Disease Not Eligible for Research Protocols Clinical research trials and Evaluation of Patients with Heart Disease Not Eligible for Research Protocols medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Evaluation of Patients with Heart Disease Not Eligible for Research Protocols. Evaluation of Patients with Heart Disease Not Eligible for Research Protocols Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Evaluation of Patients with Heart Disease Not Eligible for Research Protocols clinical trial. Test subjects typically obtain the finest healthcare available for their Evaluation of Patients with Heart Disease Not Eligible for Research Protocols condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of Patients with Heart Disease Not Eligible for Research Protocols  Evaluation of Patients with Heart Disease Not Eligible for Research Protocols
Evaluation of Patients with Heart Disease Not Eligible for Research Protocols
For Condition: Heart Disease
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: An important mission of the National Institutes of Health (NIH) is to develop and carry out research studies designed to improve understanding of disease processes and treatments. Clinical research continues to become more focused on specific diseases and the signs and symptoms of diseases in specific groups of people and patients. This study is designed to permit inpatient evaluation and care of patients with heart disease who do not qualify to participate in research studies being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). These patients are valuable to the Cardiology Branch of the NHLBI because they help to improve training and experience of its researchers.
Details: An important mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Clinical research has evolved into an increasingly narrow focus on specific diseases and disease presentations in select subgroups of patients. It is desirable, and consistent with Clinical Center policy, for clinical investigators to maintain exposure to a more broad spectrum of disease and disease presentations than mandated by clinical research protocols in order to preserve clinical skills of physician and nursing staff, ensure adequate training of clinical research fellows, and stimulate ideas for future clinical research. This protocol permits evaluation and treatment of patients with cardiovascular diseases who do not fulfill eligibility criteria for participation in existing clinical research protocols, but who are of medical interest for the purpose of training professional staff.
Eligibility:
Study Type: Interventional, Training
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Patients with cardiovascular disease who are 18 years of age or older may participate in this training protocol The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: Coronary artery disease with effort or rest angina or inducible myocardial ischemia as determined by noninvasive testing. Valvular heart disease, including patients previously operated upon by Clinical Center heart surgeons prior to 1990. Cardiomyopathies, including restrictive, congestive, and hypertrophic phenotypes. Peripheral-artery disease with intermittent claudication or limb-threatening ischemia. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. Upper extremity peripheral artery disease. Symptomatic supraventricular and ventricular arrhythmias occurring either as primary events or associated with structural or ischemic heart disease. EXCLUSION CRITERIA: Pregnancy, for those patients who require testing or treatment requiring dobutamine, gadolinium or contrast media or radiation exposure. Inability of patient, parent or legal guardian to provide informed consent.
Total Enrollment: 9999
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 950047; 95-H-0047
Study Start Date: January 6, 1995
Record last reviewed: December 5, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001458
Other Heart Disease Studies:
1. Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
2. Outpatient Evaluation of Patients with Known or Suspected Heart Disease
3. Evaluation of Patients with Heart Disease Not Eligible for Research Protocols
4. Women's Use of Alternative Medicine: A Multiethnic Study
5. Implementation of Ischemic Heart Disease Clinical Practice Guidelines
Related Studies:
Other Heart Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation of Patients with Heart Disease Not Eligible for Research Protocols
|
|
|
|
|
|
|
|
